| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2012-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b769ad9d5477508a61c9919498bba448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f8cf9bad8137cc2d701dcee2a60d8fd |
| publicationDate |
2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103282364-A |
| titleOfInvention |
Imidazo[4,5-C]quinolin-2-one compounds and their use as PI3 kinase/MTOR dual inhibitors |
| abstract |
The present invention provides an imidazo[4,5-C]quinolin-2-one compound (formula (I)) or a pharmaceutically acceptable salt thereof, which can inhibit both PI3K and MTOR, so it can be used for the treatment of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564929-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109310685-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298362-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11376259-B2 |
| priorityDate |
2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |